Molena, D., Hyung, W. J., Wainberg, Z. A., Liberman, M., Folprecht, G., Diaz, I. A., Yoshikawa, T., Al-Batran, S., Cutsem, E. V., Muro, K., Grimminger, P. P., Omori, T., Lezama, M. S., Sipocz, I., Chalabi, M., Cheng, L., Heilbron, E., Robbins, S., Janjigian, Y. Y., Tabernero, J. (2026). Surgical journey for participants (pts) in the MATTERHORN trial: A global, randomized, phase 3 study of durvalumab (D) plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric/gastroesophageal junction (G/GEJ) adenocarcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.353